DE602004017884D1 - Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren - Google Patents

Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren

Info

Publication number
DE602004017884D1
DE602004017884D1 DE602004017884T DE602004017884T DE602004017884D1 DE 602004017884 D1 DE602004017884 D1 DE 602004017884D1 DE 602004017884 T DE602004017884 T DE 602004017884T DE 602004017884 T DE602004017884 T DE 602004017884T DE 602004017884 D1 DE602004017884 D1 DE 602004017884D1
Authority
DE
Germany
Prior art keywords
protein kinase
stocks
fluorescence
kinase inhibitors
binding assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004017884T
Other languages
English (en)
Inventor
Anthony S Prokopowicz
Martha Priscilla Brown
Jessi Marie Jones-Wildeson
Scott Jakes
Mark E Labadia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharmaceuticals Inc
Publication of DE602004017884D1 publication Critical patent/DE602004017884D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B11/00Diaryl- or thriarylmethane dyes
    • C09B11/04Diaryl- or thriarylmethane dyes derived from triarylmethanes, i.e. central C-atom is substituted by amino, cyano, alkyl
    • C09B11/10Amino derivatives of triarylmethanes
    • C09B11/24Phthaleins containing amino groups ; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B55/00Azomethine dyes
    • C09B55/002Monoazomethine dyes
    • C09B55/003Monoazomethine dyes with the -C=N- group attached to an heteroring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602004017884T 2003-10-03 2004-09-30 Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren Active DE602004017884D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50853903P 2003-10-03 2003-10-03
PCT/US2004/032253 WO2005033330A2 (en) 2003-10-03 2004-09-30 Fluorescent probes for use in protein kinase inhibitor binding assay

Publications (1)

Publication Number Publication Date
DE602004017884D1 true DE602004017884D1 (de) 2009-01-02

Family

ID=34421754

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004017884T Active DE602004017884D1 (de) 2003-10-03 2004-09-30 Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren

Country Status (8)

Country Link
US (2) US7125996B2 (de)
EP (1) EP1670789B1 (de)
JP (1) JP4949845B2 (de)
AT (1) ATE414701T1 (de)
CA (1) CA2541059C (de)
DE (1) DE602004017884D1 (de)
ES (1) ES2315713T3 (de)
WO (1) WO2005033330A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1490062B1 (de) * 2002-03-26 2007-12-19 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
JP4619786B2 (ja) * 2002-08-29 2011-01-26 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 炎症性、アレルギー性及び増殖性疾患の治療において糖質コルチコイドミメティックスとして使用するための3−(スルホンアミドエチル)−インドール誘導体
UY28526A1 (es) * 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) * 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US7635711B2 (en) * 2004-12-27 2009-12-22 Boehringer-Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2007057397A1 (en) * 2005-11-15 2007-05-24 Boehringer Ingelheim International Gmbh Treatment of cancer
EE200600030A (et) * 2006-08-15 2008-04-15 Tartu �likool Proteiinkinaasi fluorestsents-sond
KR20090097908A (ko) * 2006-12-06 2009-09-16 베링거 인겔하임 인터내셔날 게엠베하 글루코코르티코이드 모사물, 이의 제조 방법, 이의 약제학적 조성물 및 용도
WO2009097318A1 (en) * 2008-01-28 2009-08-06 Bristol-Myers Squibb Company A fluorescence polarization binding assay for characterizing glucokinase ligands
EP2300472B1 (de) * 2008-06-06 2012-01-18 Boehringer Ingelheim International GmbH Glucocorticoidmimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und anwendungen davon
WO2010149190A1 (en) * 2009-06-26 2010-12-29 Max-Planck-Gesellschaft Zur Novel fluorinated rhodamines as photostable fluorescent dyes for labelling and imaging techniques
EP2482072B1 (de) 2011-01-26 2016-07-06 University of Tartu Photolumineszierenden sonde
EP2700946A1 (de) * 2012-08-24 2014-02-26 University of Tartu Bisubstratfluoreszente Sonden für Proteinkinase CK2
CN114292281B (zh) * 2021-12-22 2023-10-24 东南大学 一种用于实现细胞内脂滴动态成像的小分子荧光探针及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06172312A (ja) * 1992-03-04 1994-06-21 Wako Pure Chem Ind Ltd 1級アミノ基を有する化合物の蛍光標識化方法
JP3851706B2 (ja) * 1996-05-20 2006-11-29 日清紡績株式会社 蛍光性基含有カルボジイミド化合物
DE19816624A1 (de) * 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US6169106B1 (en) 1998-04-15 2001-01-02 Boehringer Ingelheim Pharma Kg Indolinones having kinase inhibitory activity
CN1319090A (zh) * 1998-09-25 2001-10-24 贝林格尔英格海姆法玛公司 新的取代的二氢吲哚酮、它们的制备方法和它们作为药物的用途
WO2003012046A2 (en) * 2001-07-27 2003-02-13 The Regents Of The University Of California Stk15 (stk6) gene polymorphism and methods of determining cancer risk
GB0124299D0 (en) * 2001-10-10 2001-11-28 Astrazeneca Ab Crystal structure of enzyme and uses thereof
CA2463989C (en) * 2001-10-17 2012-01-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
ATE440087T1 (de) * 2003-01-30 2009-09-15 Boehringer Ingelheim Pharma 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen

Also Published As

Publication number Publication date
US20050100978A1 (en) 2005-05-12
JP2007509845A (ja) 2007-04-19
CA2541059C (en) 2013-09-17
US7588899B2 (en) 2009-09-15
US20060263841A1 (en) 2006-11-23
JP4949845B2 (ja) 2012-06-13
EP1670789B1 (de) 2008-11-19
WO2005033330A3 (en) 2005-07-28
CA2541059A1 (en) 2005-04-14
WO2005033330A2 (en) 2005-04-14
ATE414701T1 (de) 2008-12-15
EP1670789A2 (de) 2006-06-21
ES2315713T3 (es) 2009-04-01
US7125996B2 (en) 2006-10-24

Similar Documents

Publication Publication Date Title
DE602004017884D1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
ATE480643T1 (de) Homogener nachweis von analyten
UA93989C2 (ru) Способ прогнозирования otbeta ha лечение
NO20074389L (no) Bestemmelse av respondere til kjemoterapi
DE60215626D1 (de) Antagonist für die multimerisierung von hiv-1 vif-protein
ATE540114T1 (de) Verfahren und zusammensetzungen zur schnellen isolierung kleiner rna-moleküle
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE395336T1 (de) Chinolinderivate zur verwendung als inhibitoren von mycobakterien
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
CY1115640T1 (el) Διαγνωση και αγωγη εναντι της σχιζοφρενειας
ATE365319T1 (de) Methode zur identifizierung von regulatoren der bildung von protein-age-derivaten
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
ATE404692T1 (de) Screening-verfahren zur identifizierung von tau- protein modulierenden substanzen.
ATE345397T1 (de) Verfahren zur isolierung von bakterien aus biologischen proben
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE487141T1 (de) Hemmung von gasc1
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
DE60221550D1 (de) Methode zur bestimmung der zellzyklusposition
DE60025336D1 (de) Verfahren und kit zur früherkennung von krebs
ATE503999T1 (de) Stabiles, chromogenes testreagenz und dessen verwendung in gerinnungsdiagnostischen tests
ATE500505T1 (de) Enzymhemmungsimmunverfahren
WO2007127002A3 (en) Protein markers of responsiveness to type iii receptor tyrosine kinase inhibitors
ATE447610T1 (de) Kristalliner vap-1 und verwendung
ATE430317T1 (de) Enzymatische messung von imatinib-mesylat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition